← The Wire
TOVXNYSE
Theriva Biologics, Inc.
Pharmaceutical Preparations · NV · CIK 894158
Developing oncolytic adenovirus therapeutics to treat cancer and related diseases
$14M
Market cap
$0.26
Last close
+4.1%
1D
+2.8%
5D
1.2M
Volume
Price · last 39 sessions-31.5%
May 4L $0.24 · H $0.38Jun 29
572
Total filings
Jun 29, 2026
Last filing
12/31
Fiscal year end
DEFA14ADEFA14ANov 12, 2025DEFA14ADEFA14AAug 11, 2022DEFA14ADEFA14AAug 1, 2022DEFA14ASCHEDULE 14AOct 6, 2021DEFA14ADEFA14ASep 21, 2021DEFA14ADEFA14AAug 9, 2018DEFA14ADEFA 14AJul 18, 2017DEFA14ADEFA14AAug 8, 2016DEFA14ADEFA14AJul 6, 2016DEFA14ADEFA14AApr 13, 2015DEFA14ADEFA14AMay 12, 2014DEFA14ASCHEDULE 14ASep 24, 2013DEFA14ADEFA14ASep 11, 2012DEFA14ADEFA14AJun 20, 2011
Similar companies
Comparable business profile · signals at a glance